DiaSorin SpA
Chen M. Even is Chief Commercial Officer of the DiaSorin Group. Born 1963, he graduated in ICT in 1989. In 1995, he completed a research doctorate in virology and immunology at the University of Minnesota School of medicine and he interned at the neurology department of the University of California (Irvine).
He has been part of DiaSorin since 1996, taking part in the management buyout in 2000 and holding various roles within the group, such as Vice President – Export, Marketing Director for hepatitis and viral diseases family of products, Head of the molecular biology project conducted in North America and Senior Corporate VP Commercial Operations.
Since 2003 he is a member of the Board of Directors of Diasorin S.p.A. In 2016 he was appointed Chief Commercial Officer, a position he still holds today.
This person is not in any offices
DiaSorin SpA
4 followers
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.